<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------------
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
March 31, 1995
----------------
Date of Report
(Date of earliest event reported)
NEORX CORPORATION
----------------------------------------------
(Exact name of registrant as specified in its charter)
Washington 0-16614 91-1261311
- - ------------------ ----------- ---------------
(State or other jurisdiction (Commission File No.) (IRS Employer
of incorporation) Identification No.)
410 West Harrison St.
Seattle, Washington 98119
----------------------------
(Address of principal executive offices, including zip code)
(206) 281-7001
-----------------------
(Registrant's telephone number, including area code)
Page 1 of 3
<PAGE> 2
Item 5. Other Events
The Company has been named as an additional codefendant in an amended
complaint filed in a pending purported class action suit against David Blech,
D. Blech & Co. and a number of other defendants, including eleven publicly
traded biotechnology companies. The complaint seeks damages for alleged
unlawful manipulation of the stock market prices of the named biotechnology
companies. The Company believes that the claims against it have no factual or
legal basis and are without merit. Although the complaint alleges that D. Blech
& Co. was the principal market maker for NeoRx Corporation stock, to the
Company's knowledge D. Blech & Co. was never a significant market maker for the
Company's stock. The Compnay intends to defend this suit vigorously.
Page 2
<PAGE> 3
SIGNATURE
Pursuant to the requirements of the Exchange Act, the registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
NEORX CORPORATION
Dated: March 31, 1995
By /s/ Robert M. Littauer
-----------------------------------
Robert M. Littauer,
Senior Vice President, Chief
Financial Officer and Treasurer
Page 3
